The biotechnology company develops therapeutic solutions targeting specific biological pathways involved in weight regulation to address obesity. Their platform identifies and creates novel molecules that provide effective treatment options for individuals struggling with body weight management.
Funding
$4.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Obesity and related weight management issues affect a significant portion of the population, leading to various health complications. Current therapeutic options may not be effective or have undesirable side effects, highlighting the need for novel and targeted treatments.
Solution
Ektah is a biotechnology company focused on developing therapeutic solutions for body weight reduction. The company identifies and develops novel molecules that target specific biological pathways involved in weight regulation. Ektah leverages its research and development capabilities to create effective treatment options for individuals struggling with weight management. The company also offers services for third parties, including anorexigenic peptide level measurement, and is ISO 9001 certified.
Target Audience
Ektah's primary customers are individuals seeking effective therapeutic approaches to body weight reduction, as well as third parties requiring anorexigenic peptide level measurement services.
Features
- Identification of novel molecules targeting weight regulation pathways
- Development of therapeutic solutions for body weight reduction
- R&D capabilities for continuous molecule discovery
- Services for third parties, including anorexigenic peptide level measurement
- ISO 9001 certified services